Nemera expands diabetes device portfolio and prepares for the future
March 1, 2021Read moreThe latest issue of ‘Pharmaceutical Post’ is highlighted diabetes device portfolio and the evolution
Nemera is committed to Gender Equality
February 26, 2021Read moreThe Gender Equality Index 2020 has well improved. As of 2019, Nemera shared its overall ambitions with its staff concerning gender parity for 2022, and has committed to equality in terms of employment, professional development and promotions for all its employees.
The right route to take: the smart device that can help manage drug overdosing
February 19, 2021Read moreThe latest issue of ‘EPM’ is highlighted Safe’n’Spray, the smart device that can help manage drug overdosing
Nemera’s holistic approach to dermal drug delivery
January 26, 2021Read moreThe latest issue of ‘Skin Drug Delivery’ is highlighted Nemera’s holistic approach in dermal pharmaceutical application.
A new statistical method to assess in vitro bioequivalence of nasal products
January 20, 2021Read moreThis article presents the so called Between-Batch Bioequivalence (BBE) method, evaluated through both simulation and real-case (Nasonex® & Flonase®) studies.
